AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
16.1 USD
+0.09 (+0.56%)
16.1 USD
0 (0%)
AMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
AMN had positive earnings in 4 of the past 5 years.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AMN has a worse Return On Assets (-12.88%) than 75.49% of its industry peers.
With a Return On Equity value of -42.76%, AMN is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
AMN has a Return On Invested Capital of 2.08%. This is comparable to the rest of the industry: AMN outperforms 47.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.61%.
The last Return On Invested Capital (2.08%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (1.65%) which is in line with its industry peers.
AMN's Operating Margin has declined in the last couple of years.
AMN's Gross Margin of 29.37% is in line compared to the rest of the industry. AMN outperforms 57.84% of its industry peers.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
Compared to 1 year ago, AMN has more shares outstanding
AMN has less shares outstanding than it did 5 years ago.
AMN has a better debt/assets ratio than last year.
2.2 Solvency
AMN has an Altman-Z score of 2.40. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.40, AMN perfoms like the industry average, outperforming 53.92% of the companies in the same industry.
The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
AMN has a Debt to FCF ratio of 3.80. This is in the better half of the industry: AMN outperforms 72.55% of its industry peers.
A Debt/Equity ratio of 1.31 is on the high side and indicates that AMN has dependencies on debt financing.
AMN has a worse Debt to Equity ratio (1.31) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.26
WACC7.87%
2.3 Liquidity
A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
AMN's Current ratio of 1.05 is on the low side compared to the rest of the industry. AMN is outperformed by 68.63% of its industry peers.
A Quick Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
The Quick ratio of AMN (1.05) is worse than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -51.29% in the last year.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
The Revenue for AMN has decreased by -11.42% in the past year. This is quite bad
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AMN is valuated reasonably with a Price/Earnings ratio of 8.52.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 95.10% of the companies listed in the same industry.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.57.
The Price/Forward Earnings ratio is 20.85, which indicates a rather expensive current valuation of AMN.
The rest of the industry has a similar Price/Forward Earnings ratio as AMN.
AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.52 | ||
| Fwd PE | 20.85 |
4.2 Price Multiples
84.31% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 99.02% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.78 | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -29.55% in the coming years.
PEG (NY)N/A
PEG (5Y)10.59
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
16.1
+0.09 (+0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.78%
Inst Owner Change0.21%
Ins Owners0.43%
Ins Owner Change2.77%
Market Cap618.40M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.13 (31.24%)
Short Float %6.73%
Short Ratio2.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)0.69%
PT rev (3m)3.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41.93%
EPS NY rev (1m)20.88%
EPS NY rev (3m)18.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.48%
Revenue NY rev (1m)4.59%
Revenue NY rev (3m)4.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.52 | ||
| Fwd PE | 20.85 | ||
| P/S | 0.23 | ||
| P/FCF | 2.78 | ||
| P/OCF | 2.32 | ||
| P/B | 0.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.85 |
EPS(TTM)1.89
EY11.74%
EPS(NY)0.77
Fwd EY4.8%
FCF(TTM)5.8
FCFY36.03%
OCF(TTM)6.94
OCFY43.13%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.59
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.4 |
F-Score4
WACC7.87%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y21.54%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.